PATENT CLAIM ANALYSIS

Application Number: 16193269
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["544", "277000"]

Abstract:
Embodiments of calcium channel agonists, as well as methods of making and using the calcium channel agonists, are disclosed. The disclosed calcium channel agonists and corresponding salt forms have a structure according to general formula I: wherein each bond depicted as “ ” is a single bond or a double bond as needed to satisfy valence requirements; Z 1 , Z 2 , Z 3 , Z 4 , and Z 5  independently are nitrogen or carbon; R 1  and R 3  are alkyl; R 2  is alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; and R 4  is alkyl or hydroxyalkyl.

Claim (Index 14):
The method of  claim 2 , wherein R 3  is ethyl.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.88333
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15711715', '14892184', '15842823', '16022578', '15897796']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7894808292505031
- 35 USC 102 Novelty (BERT): 0.6339365714699241
- Combined Prediction Score: 0.7739264034724452
- Mean Citation Score: 404.681562
- Max Citation Score: 685.0573
- Similarity Product: 532.2300766986192

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test